GRAIL, Inc.

GRAL ·Healthcare, Medical Care Facilities, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023
Operating Activities
Net Income $-408.4M $-2.03B $-1.47B
Depreciation & Amortization
Depreciation $18.0M $19.7M $20.4M
Amortization $133.9M $133.9M $133.9M
Stock-Based Compensation $58.3M $86.1M $97.2M
Net Cash from Operating Activities $-299.0M $-577.2M $-595.8M
Investing Activities
Capital Expenditures $909.0K $5.2M $12.9M
Business Acquisitions
Net Cash from Investing Activities $-85.0M $-551.0M $-12.9M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $423.3M $1.24B $463.8M
Net Change in Cash $39.1M $116.1M $-144.6M
Free Cash Flow $-299.9M $-582.4M $-608.7M